Semaglutide
Weight reduction can improve overall body composition and reduce fat mass, which is why it is often framed within aesthetic outcomes.
View medication pageTherapy Hub
Aesthetics
Aesthetic medicine increasingly overlaps with metabolic medicine because improvements in fat mass, body composition, and tissue quality can influence visible outcomes. This category includes therapies commonly positioned for aesthetic framing when body composition change, weight reduction, or GH-axis support may indirectly affect appearance, contour, or perceived vitality.
Available Medications
Each medication below is grouped here because its mechanism, clinical use, or published literature helps explain why it fits this therapy category.
Tirzepatide
Produces substantial weight loss and favorable body-composition changes, often with larger average reductions than prior agents.
View medication pageSermorelin
Indirectly tied to aesthetic positioning through body composition effects and literature discussing skin and soft-tissue changes through the GH/IGF-1 axis.
View medication pageMore Medications Available
This is not a comprehensive list of our available medications. We have what you need.
Contact us for moreReferences
Studies, data, and supporting evidence
These references support the positioning statements used on this therapy hub. They are intended as educational source material for patients and prescribers, not as a substitute for individualized medical judgment.
Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity
Semaglutide reduced total and visceral fat mass while increasing the proportion of lean body mass, supporting why it is often discussed in aesthetics and body-composition programs.
Full Text →Tirzepatide Once Weekly for the Treatment of Obesity
SURMOUNT-1 established the magnitude of tirzepatide's average weight loss, which underlies much of its aesthetic framing in body-transformation settings.
PubMed →The Effect of Tirzepatide on Body Composition in People with Overweight and Obesity
Systematic review finding tirzepatide significantly reduces fat mass, visceral adipose tissue, and waist circumference, supporting its body-composition relevance.
Full Text →Effects of Human Growth Hormone in Men over 60 Years Old
Classic data reported lean-mass gains, reduced adipose tissue, and increased skin thickness, which is why GH-axis therapies like sermorelin are sometimes positioned for indirect aesthetic benefit.
PubMed →Evidence strength is not identical across all therapies. Some placements are supported by FDA labeling or landmark randomized trials, while others rely more heavily on mechanistic, adjunctive, or early-stage literature and should be framed accordingly.